Kentucky Attorney General Jack Conway announced a lawsuit against Johnson & Johnson and subsidiaries for violating the Kentucky Consumer Protection Act by unfair, false, misleading, or deceptive labeling and promotion of its antipsychotic drug Risperdal. The lawsuit alleges that J&J hid the risks of Risperdal from Kentucky patients and doctors. Conway’s lawsuit seeks injunctive relief and civil penalties of up to $2,000 per violation and up to $10,000 per violation directed at consumers over age 60. The injunctive relief sought would seek to prevent J&J from future promotion or marketing of its drugs within the Commonwealth in an unfair, false, misleading or deceptive way.